Octreotide attenuates impaired microcirculation in postischemic pancreatitis when administered before induction of ischemia

Transplantation

Volumn 86, Issue 7, 2008, Pages 961-967

  Woeste, Guido ^a   Wullstein, Christoph ^a   Meyer, Sebastian ^b   Usadel, Klaus H ^c   Hopt, Ulrich T ^b   Bechstein, Wolf O ^a   Von Dobschuetz, Ernst ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Endokrinologikum Frankfurt   (Germany)

Author keywords

Ischemia; Octreotide; Pancreas; Reperfusion

Indexed keywords

AMYLASE; OCTREOTIDE; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM; FLUORESCENCE MICROSCOPY; ISCHEMIA; LEUKOCYTE; MALE; MICROCIRCULATION; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ANIMAL; BLOOD GAS ANALYSIS; CAPILLARY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GAS ANALYSIS; CAPILLARIES; INFUSIONS, INTRAVENOUS; ISCHEMIA; MALE; MICROCIRCULATION; OCTREOTIDE; PANCREATITIS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 56049106352     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318186b783     Document Type: Article

References (39)

1. Becker BN, Brazy PC, Becker YT, et al. Simultaneous pancreas-kidney transplantation reduces excess mortalityintype1 diabetic patients with end-stage renal disease. Kidney Int 2000; 57: 2129.
2. Gross CR, Limwattananon C, Matthees B, et al. Impact of transplanta- tion on quality of life in patients with diabetes and renal dysfunction. Transplantation 2000; 70: 1736.
3. Gruessner RW, Sutherland DE, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2004; 4: 2018.
4. Ojo AO, Meier-Kriesche HU, Hanson JA, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71: 82.
5. Smets YF, Westendorp RG, van der Pijl JW,et al. Effectofsimultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999; 353: 1915.
6. Sureshkumar KK, Mubin T, Mikhael N, et al. Assessment of quality of life after simultaneous pancreas-kidney transplantation. Am J Kidney Dis 2002; 39: 1300.
7. Andreoni KA, Brayman KL, Guidinger MK, et al. Kidney and pancreas transplantationin the United States, 1996-2005.Am J Transplant2007; 7: 1359.
8. Burke GW, Ciancio G, Sollinger HW. Advances in pancreas transplantation. Transplantation 2004; 77: S62.
9. Humar A, Kandaswamy R, Granger D, et al. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000; 231: 269.
10. Troppmann C, Gruessner AC, Dunn DL, et al. Surgical complications requiring early relaparotomy after pancreas transplantation: A multi-variate risk factor and economic impact analysis of the cyclosporine era. Ann Surg 1998; 227: 255.
11. Woeste G, Wullstein C, Vogt J, et al. Value of donor swabs for intraabdominal infectionin simultaneous pancreas-kidney transplantation. Transplantation 2003; 76: 1073.
12. Von Dobschuetz E, Pahernik S, Hoffmann T, et al. Dynamic intravital fluorescence microscopy - A novel method for the assessment of microvascular permeability in acute pancreatitis. Microvasc Res 2004; 67: 55.
13. Kusterer K, Buchheit KH, Schade A, et al. The somatostatin analogue octreotide protects against ethanol-induced microcirculatory stasis and elevated vascular permeability in rat gastric mucosa. Eur J Pharmacol 1994; 259: 265.
14. Plusczyk T, Rathgeb D, Westermann S, et al. Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis. Dig Dis Sci 1998; 43: 575.
15. Schwedes U, Althoff PH, Klempa I, et al. Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog. Horm Metab Res 1979; 11: 655.
16. Usadel KH. Hormonal and nonhormonal cytoprotective effect by so-matostatins. Horm Res 1988; 29: 83.
17. Hoffmann TF, Uhl E, Messmer K. Protective effect of the somatostatin analogue octreotide in ischemia/reperfusion-induced acute pancreatitis in rats. Pancreas 1996; 12: 286.
18. Warshaw AL. Ischemia- and reperfusion-related injury in pancreatitis. Dig Dis Sci 1996; 41: 821.
19. Hoffmann TF, Leiderer R,Waldner H,et al. Ischemia reperfusion of the pancreas: A new in vivo model for acute pancreatitis in rats. Res Exp Med (Berl) 1995; 195: 125.
20. Yuan F, Leunig M, Berk DA, et al. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Micro-vasc Res 1993; 45: 269.
21. Benz S, Bergt S, Obermaier R, et al. Impairment of microcirculation in the early reperfusion period predicts the degree of graft pancreatitis in clinical pancreas transplantation. Transplantation 2001; 71: 759.
22. Dembinski A, Warzecha Z, Ceranowicz P, et al. Pancreatic damage and regeneration in the course of ischemia-reperfusion induced pancreatitis in rats. J Physiol Pharmacol 2001; 52: 221.
23. Busing M, Hopt UT, Quacken M, et al. Morphological studies of graft pancreatitis following pancreas transplantation. Br J Surg 1993; 80: 1170.
24. Grewal HP, Garland L, Novak K,et al. Risk factors for postimplantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients. Transplantation 1993; 56: 609.
25. Wullstein C, Drognitz O, Woeste G, et al. High levels of C-reactive protein after simultaneous pancreas-kidney transplantation predict pancreas graft-related complications and graft survival. Transpla ntation 2004; 77: 60.
26. Klar E, Schratt W, Foitzik T, et al. Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotiz-ing pancreatitis in rabbit pancreas. Dig Dis Sci 1994; 39: 2639.
27. Kusterer K, Poschmann T, Friedemann A, et al. Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol 1993; 265: G165.
28. Menger MD, Bonkhoff H, Vollmar B. Ischemia-reperfusion-induced pancreatic microvascular injury. An intravital fluorescence microscopic study in rats. Dig Dis Sci 1996; 41: 823.
29. Usadel KH, Leuschner U, Uberla KK. Treatment of acute pancreatitis with somatostatin: A multicenter double blind study. N Engl J Med 1980; 303: 999.
30. Boden G, Sivitz MC, Owen OE, et al. Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 1975; 190: 163.
31. Dollinger HC, Raptis S. Inhibition of exocrine and endocrine pancreatic function by somatostatin in man. Z Gastroenterol Verh 1976; 56.
32. Heintges T, Luthen R, Niederau C. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues. Digestion 1994; 55(suppl 1): 1.
33. Klar E, Werner J. [New pathophysiologic knowledge about acute pancreatitis.] Chirurg 2000; 71: 253.
34. Mithofer K, Fernandez-del CC, Frick TW, et al. Increased intrapancre-atic trypsinogen activation in ischemia-induced experimental pancreatitis. Ann Surg 1995; 221: 364.
35. Von Dobschuetz E, Bleiziffer O, Pahernik S, et al. Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in the rat. Am J Physiol Gastrointest Liver Physiol 2004; 286: G791.
36. Von Dobschuetz E, Meyer S, Thorn D, et al. Targeting vascular endo-thelial growth factor pathway offers new possibilities to counteract mi-crovascular disturbances during ischemia/reperfusion of the pancreas. Transplantation 2006; 82: 543.
37. Helyes Z, Pinter E, Nemeth J, et al. Anti-inflammatory effect of synthetic somatostatin analogues in the rat. Br J Pharmacol 2001; 134: 1571.
38. Benedetti E, Coady NT, Asolati M, et al. A prospective randomized clinical trial of perioperative treatment with octreotide in pancreas transplantation. Am J Surg 1998; 175: 14.
39. Hesse UJ, Meester D, Troisi R, et al. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial. Clin Transplant 2005; 19: 299.